| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |